<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ETANERCEPT <img border="0" src="../images/pr.gif"/></span><br/>(e-tan'er-cept)<br/><span class="topboxtradename">Enbrel<br/></span><b>Classifications:</b> <span class="classification">biologic response modifier</span>; <span class="classification">tumor necrosis factor modifier</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>25 mg, 50 mg injection; 50 mg/mL prefilled syringe</p>
<h1><a name="action">Actions</a></h1>
<p>Produced by recombinant DNA technology. Binds specifically to tumor necrosis factor (TNF) and blocks it from attaching to
         cell surface TNF receptors.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Indicated by improved RA symptomatology. This naturally occurring cytokine (e.g., IL-6) is part of the normal immune and inflammatory
         response. TNF mediates inflammation and modulates cellular immune responses. Elevated levels of TNF are found in the synovial
         fluids of rheumatoid arthritis (RA) patients.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Reduction of the signs and symptoms of RA and psoriatic RA in adults, and polyarticular juvenile RA (JRA) in children with
         inadequate response to other disease-modifying antirheumatic drugs. Treatment of ankylosing spondylitis.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Patients with sepsis or other active infection; agranulocytosis; hypersensitivity to etanercept; malignancy; benzyl alcohol
         hypersensitivity; bleeding, hematologic disease, fever, infection; intramuscular administration, intravenous administration;
         latex hypersensitivity; sepsis; varicella; lactation.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Immunosuppression; autoimmune disease, bone marrow suppression; diabetes mellitus; hamster protein hypersensitivity; heart
         failure; multiple sclerosis, neoplastic disease, neurological disease, seizure disorder, seizures; pregnancy (category B).
         Safety and efficacy in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">SC</span> 25 mg twice weekly; or 0.08 mg/kg or 50 mg once weekly<br/><span class="rdage">Child:</span> <span class="rdroute">SC</span> <i>&gt;4 y</i>, 0.4 mg/kg (max: 25 mg/dose) twice weekly<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Subcutaneous</span><br/><ul>
<li>Do not administer to a patient who has known or suspected sepsis.</li>
<li>Reconstitute by slowly injecting the supplied diluent into the vial. Swirl gently to dissolve and do not shake. Reconstituted
            solution should be clear and colorless. Use within 6 h.
         </li>
<li>Inject into thigh, abdomen, upper arm; rotate injection sites and never inject into an old injection site or where skin is
            tender, bruised, red, or hard.
         </li>
<li>Store reconstituted solution up to 6 h refrigerated at 2°8° C (36°46° F). Store unopened dose
            tray refrigerated at 2°8° C (36°46° F).
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Asthenia, serious <span class="speceff-common">infections,</span> sepsis, monitor for reactivation of tuberculosis. <span class="typehead">CNS:</span> Headache, dizziness, cerebral ischemia, depression, demyelinating disorders (multiple sclerosis, myelitis, optic neuritis). <span class="typehead">CV:</span> Heart failure, <span class="speceff-life">MI</span>, myocardial ischemia, hypertension, hypotension. <span class="typehead">GI:</span> Abdominal pain, dyspepsia, cholecystitis, pancreatitis, GI hemorrhage. <span class="typehead">Respiratory:</span> Rhinitis, URI, pharyngitis, cough, respiratory disorder, sinusitis, dyspnea may reactivate latent tuberculosis (TB). <span class="typehead">Skin:</span> Rash; injection site reactions (<span class="speceff-common">erythema, itching, pain, swelling</span>). <span class="typehead">Musculoskeletal:</span> Bursitis. <span class="typehead">Hematologic:</span> <span class="speceff-life">Pancytopenia</span>. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span> Concurrent or recent use with <b>azathioprine,</b> <b>cyclophosphamide,</b> <b>leflunomide,</b> <b>methotrexate</b> has been associated with pancytopenia. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead"> Onset:</span>  12 wk. <span class="typehead">Peak:</span> 72 h. <span class="typehead">Half-Life:</span> 115 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor carefully for and immediately report S&amp;S of infection.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>A PPD test is recommended before starting therapy to check for TB.</li>
<li>Discard all needles and syringes after use; do not reuse.</li>
<li>Withhold etanercept and notify physician before resuming drug if you develop an infection or are exposed to varicella virus.</li>
<li>Avoid vaccinations, in general, and live vaccines, in particular, while on etanercept.</li>
<li> 							Note: Injection site reactions (e.g., redness, pain, swelling) are common in the first month of therapy but generally decrease over
            time. 						
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>